Scarica l'app Stockscreener
10.25
0.49%
0.05
Neuropace Inc Borsa (NPCE) Ultime notizie
NeuroPace's SWOT analysis: epilepsy device maker's stock poised for growth - Investing.com
NeuroPace, Inc. (NASDAQ:NPCE) Receives $14.60 Average PT from Analysts - MarketBeat
NeuroPace, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Top 10 Deep Brain Stimulation Device Companies | Provides Best DevicesMarket.us Media - Market.us Media - United States Market News
NeuroPace (NASDAQ:NPCE) versus Cerus (NASDAQ:CERS) Financial Analysis - Defense World
NeuroPace, Inc. (NPCE) Reports Q3 Loss, Tops Revenue Estimates - MSN
What Makes NeuroPace (NPCE) a New Buy Stock - MSN
Wall Street Analysts Believe NeuroPace (NPCE) Could Rally 54.34%: Here's is How to Trade - Yahoo Finance
NeuroPace FY2024 EPS Forecast Raised by Cantor Fitzgerald - Defense World
Cantor Fitzgerald Boosts Earnings Estimates for NeuroPace - MarketBeat
NeuroPace (NASDAQ:NPCE) Price Target Cut to $13.00 by Analysts at Wells Fargo & Company - Defense World
FY2024 EPS Estimates for NeuroPace Lifted by Leerink Partnrs - Defense World
NeuroPace FY2024 EPS Forecast Boosted by Leerink Partnrs - MarketBeat
NeuroPace Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance
Here's What Analysts Are Forecasting For NeuroPace, Inc. (NASDAQ:NPCE) After Its Third-Quarter Results - Simply Wall St
Long NPCE: NeuroPace Inc. Q3 Earnings, 28% Revenue Growth, Nautilus Study Progress, and Breakout from $6-$7 Consolidation Signal Bullish Momentum - Invezz
How the (NPCE) price action is used to our Advantage - Stock Traders Daily
NeuroPace price target lowered to $13 from $15 at Wells Fargo - TipRanks
NeuroPace, Inc. (NASDAQ:NPCE) Q3 2024 Earnings Call Transcript - Insider Monkey
500: Something went wrong - Investing.com Canada
NeuroPace Reports Third Quarter 2024 Financial Results and Increases 2024 Revenue Guidance - The Manila Times
NeuroPace, Inc. Reports Strong Q3 2024 Results - TipRanks
NeuroPace Inc.: Q3 Earnings Snapshot - San Francisco Chronicle
Neuropace earnings beat by $0.08, revenue topped estimates - Investing.com UK
Neuroscience Market Projected to Reach USD 50.2 Billion by 2032, Growing at a 4.0% CAGR – S&S Insider - GlobeNewswire Inc.
Earnings To Watch: NeuroPace Inc (NPCE) Reports Q3 2024 Result - Yahoo Finance
NeuroPace (NPCE) Set to Announce Earnings on Tuesday - Defense World
private equity firms who own 45% along with institutions invested in NeuroPace, Inc. (NASDAQ:NPCE) saw increase in their holdings value last week - Yahoo Finance
Does NeuroPace (NASDAQ:NPCE) Have A Healthy Balance Sheet? - Simply Wall St
NeuroPace submits RNS System study data to FDA By Investing.com - Investing.com Australia
NeuroPace (NPCE) Set to Announce Quarterly Earnings on Tuesday - MarketBeat
NeuroPace Announces FDA Submission of Three-Year Data from Post-Approval Study of the RNS System in Focal Epilepsy - ForexTV.com
NeuroPace submits RNS System study data to FDA - Investing.com India
How to Take Advantage of moves in (NPCE) - Stock Traders Daily
Analysts Set NeuroPace, Inc. (NASDAQ:NPCE) Target Price at $14.00 - Defense World
NeuroPace, Inc. (NASDAQ:NPCE) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
Strength Seen in NeuroPace (NPCE): Can Its 5.1% Jump Turn into More Strength? - MSN
Deep Brain Stimulation Devices Market Growing Popularity & Emerging Trends | Medtronic, NeuroPace, LivaNova - openPR
KCK LTD.'s Strategic Reduction in NeuroPace Inc Shares - Yahoo Finance
Neuropace shareholder KCK Ltd. sells $1.22 million in stock By Investing.com - Investing.com South Africa
Neuropace shareholder KCK Ltd. sells $1.22 million in stock - Investing.com
Ltd. Kck Sells 223,991 Shares of NeuroPace, Inc. (NASDAQ:NPCE) Stock - MarketBeat
KCK LTD. Adjusts Stake in NeuroPace Inc - GuruFocus.com
Neuropace Inc sees $24,853 stock sale by major shareholder - Investing.com
Page 85 – Impact Investing - Equities News
Neuropace stock hits 52-week low at $5.66 amid market challenges - Investing.com Australia
0.65%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):